U.S. Injectable Drug Pipeline

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injectables, intravenous injectables, intramuscular injectables, and others. Major market challenges, drivers, and restraints and identified and discussed as well as hot topics and trends relating to injectable drug development.

Table of Contents

U.S. Injectable Drug Pipeline, Executive SummaryExecutive SummaryIntroductionU.S. Injectable Drug Pipeline, Market OverviewResearch Scope and MethodologyScope and SegmentationResearch MethodologyMarket IntroductionIntroductionHot Topics and TrendsPatient Willingness to Use Injection TypesLeading CompaniesIndustry ChallengesMarket DriversMarket RestraintsU.S. Injectable Drug Pipeline, Pipeline AnalysisIntroductionPipeline OverviewIntramuscular Injectable DrugsIntroductionPhase IIIPhase II/IIIPhase IIPhase I/IIPhase ISubcutaneous Injectable DrugsIntroductionPhase IIIPhase II/IIIPhase IIPhase I/IIPhase IIntravenous Injectable DrugsIntroductionPhase IIIPhase II/IIIPhase IIPhase I/IIPhase IOther Injectable DrugsIntroductionPhase IIIPhase II/IIIPhase IIPhase I/IIPhase IU.S. Injectable Drug Pipeline, Decision Support DatabasesOncology DatabasesIncidence of Colon Rectum CancerTotal Cancer CasesIncidence of Bladder CancerIncidence of Breast CancerIncidence of Lung CancerIncidence of Stomach CancerAutoimmune and Inflammatory Disorders DatabasesPrevalence of AsthmaPrevalence of ArthritisTotal Cases of Multiple SclerosisPrevalence of PsoriasisCardiovascular Disorders DatabasesPrevalence of Cardiovascular DiseasesPrevalence of Coronary Heart Disease




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 15-Nov-17

Region : North America

Release Date : 15-Nov-17

Region : North America

Release Date : 13-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.